Collins Helen Louise
SEC insider (Form 3/4/5 filer). CIK 0001701247. CHIEF MEDICAL OFFICER at Enliven Therapeutics, Inc. (ELVN) and 2 other issuers. 44 reported Form 4/5 transactions since Sep 2024; latest on Oct 19, 2026. Located in BURLINGAME, CA.
Companies Collins Helen Louise has filed insider reports for
- Enliven Therapeutics, Inc. (ELVN): Officer, CHIEF MEDICAL OFFICER
- Kura Oncology, Inc. (KURA): Director
- IO Biotech, Inc. (IOBT): Director
Collins Helen Louise
CIK: 0001701247
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (44 total)
- Oct 19, 2026ELVN
Enliven Therapeutics, Inc.
ExerciseDirect5K shares at avg. $2.48$12K - Oct 19, 2026ELVN
Enliven Therapeutics, Inc.
SaleDirect5K shares at avg. $38.47$192K - Sep 17, 2026ELVN
Enliven Therapeutics, Inc.
ExerciseDirect5K shares at avg. $2.48$12K - Sep 17, 2026ELVN
Enliven Therapeutics, Inc.
SaleDirect1.8K shares at avg. $50.71$94K - Sep 17, 2026ELVN
Enliven Therapeutics, Inc.
SaleDirect2.9K shares at avg. $50.03$146K - Sep 17, 2026ELVN
Enliven Therapeutics, Inc.
SaleDirect240 shares at avg. $51.48$12K - Aug 17, 2026ELVN
Enliven Therapeutics, Inc.
ExerciseDirect5K shares at avg. $2.48$12K - Aug 17, 2026ELVN
Enliven Therapeutics, Inc.
SaleDirect1.1K shares at avg. $59.35$65K - Aug 17, 2026ELVN
Enliven Therapeutics, Inc.
SaleDirect3.9K shares at avg. $58.37$228K - Jul 17, 2026ELVN
Enliven Therapeutics, Inc.
SaleDirect63 shares at avg. $53.92$3K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 19, 2026 |  ELVN Enliven Therapeutics, Inc. | Exercise | 5,000 | $2.48 | $12,400 | Direct |
| Oct 19, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 5,000 | $38.47 | $192,342 | Direct |
| Sep 17, 2026 | ELVN Enliven Therapeutics, Inc. | Exercise | 5,000 | $2.48 | $12,400 | Direct |
| Sep 17, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 1,844 | $50.71 | $93,507 | Direct |
| Sep 17, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 2,916 | $50.03 | $145,891 | Direct |
| Sep 17, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 240 | $51.48 | $12,356 | Direct |
| Aug 17, 2026 | ELVN Enliven Therapeutics, Inc. | Exercise | 5,000 | $2.48 | $12,400 | Direct |
| Aug 17, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 1,100 | $59.35 | $65,281 | Direct |
| Aug 17, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 3,900 | $58.37 | $227,650 | Direct |
| Jul 17, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 63 | $53.92 | $3,397 | Direct |
1-10 of 44 transactions